Company Analysis
Sign in

Pharvaris N.V. (PHVS)

Nasdaq: PHVS · Pharmaceutical Preparations · Leiden, NL · filing with the SEC since 2020
Full chart Alerts Compare
Grade6.0
◀ Past 5.7● Present 5.6▶ Future 6.6
7 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Income statement, as filed

In euros (EUR), as filed; per-share figures in euros; share counts. The fiscal year ends in December.
Income statement, by fiscal year, newest first
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period endingDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018
Report filedApr 2, 2026Apr 7, 2025Apr 10, 2024Apr 5, 2023Mar 29, 2022Apr 29, 2021··
For lenders
Net interest income6,535,0465,469,464224,494-16,105-267,510···
Research and development124,478,33498,563,52965,575,03057,375,57435,789,16619,508,1015,684,5623,645,413
General and administrative45,344,59847,124,63831,338,59029,339,03418,349,4605,498,4912,325,719668,121
Total operating expenses169,822,932145,688,16796,913,62086,714,60854,138,62625,006,5928,010,2814,313,534
Operating income-173,711,496-132,396,503-99,826,263-75,653,470-42,660,662-26,068,955-8,027,162-4,313,914
Finance costs···16,105267,51092,47016,881380
Net finance income (costs)-3,888,56413,291,664-2,912,64311,061,13811,477,964-1,062,363-16,881·
Income before income taxes-173,711,496-132,396,503-99,826,263-75,653,470-42,660,662-26,068,955-8,027,162-4,313,914
Income tax expense1,987,9011,825,0241,048,805679,08770,117-83,25100
Net income-175,699,397-134,221,527-100,875,068-76,332,557-42,730,779-25,985,704-8,027,162-4,313,914
Net income to shareholders····-42,700,486-25,990,069··
Earnings per share, basic-2.97-2.48-2.63-2.27-1.40···
Earnings per share, diluted-2.97-2.48-2.63-2.27-1.40···
Earnings per share, basic and diluted·····-5.36-1.66-0.89
Weighted average shares, diluted59,159,24754,020,54938,391,65433,585,97630,411,9024,850,0004,850,0004,850,000
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Net interest income interest earned less interest paidifrs-full:InterestRevenueExpense
Research and development spent on inventing what it sells nextifrs-full:ResearchAndDevelopmentExpense
General and administrative the cost of running the company itselfifrs-full:GeneralAndAdministrativeExpense
Total operating expenses the running costs togetherifrs-full:OperatingExpense
Operating income profit from running the business, before interest and taxifrs-full:ProfitLossFromOperatingActivities
Finance costs what its borrowing costifrs-full:InterestExpense
ifrs-full:FinanceCosts
Net finance income (costs) interest earned less interest paid, outside the businessifrs-full:FinanceIncomeCost
Income before income taxes profit before taxifrs-full:ProfitLossBeforeTax
Income tax expense tax charged on the period's profitifrs-full:IncomeTaxExpenseContinuingOperations
Net income the whole group's profit, minority holders' share includedifrs-full:ProfitLoss
Net income to shareholders the profit or loss that belongs to the company's shareholdersifrs-full:ProfitLossAttributableToOwnersOfParent
Earnings per share, basic net income per share outstandingifrs-full:BasicEarningsLossPerShare
Earnings per share, diluted net income per share, counting every share that could be issuedifrs-full:DilutedEarningsLossPerShare
Earnings per share, basic and diluted net income per share, where both counts are the sameifrs-full:BasicAndDilutedEarningsLossPerShare
Weighted average shares, diluted the average count with every share that could be issuedifrs-full:AdjustedWeightedAverageShares
SI Assistanton PHVS · research, not advice